How H13 histocompatibility peptides differing by a single methyl group and lacking conventional MHC binding anchor motifs determine self-nonself discrimination

被引:36
作者
Ostrov, DA
Roden, MM
Shi, WX
Palmieri, E
Christianson, GJ
Mendoza, L
Villaflor, G
Tilley, D
Shastri, N
Grey, H
Almo, SC
Roopenian, D
Nathenson, SG
机构
[1] Jackson Lab, Bar Harbor, ME 04609 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA
[5] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[6] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA
关键词
D O I
10.4049/jimmunol.168.1.283
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mouse H13 minor histocompatibility (H) Ag, originally detected as a barrier to allograft transplants, is remarkable in that rejection is a consequence of an extremely subtle interchange, P4(Val/Ile), in a nonamer H2-D-b-bound peptide. Moreover, H13 peptides lack the canonical P5(Asn) central anchor residue normally considered important for forming a peptide/MHC complex. To understand how these noncanonical peptide pMHC complexes form physiologically active TCR ligands, crystal structures of allelic H13 pD(b) complexes and a P5(Asn) anchored pD(b) analog were solved to high resolution. The structures show that the basis of TCRs to distinguish self from nonself H13 peptides is their ability to distinguish a single solvent-exposed methyl group. In addition, the structures demonstrate that there is no need for H13 peptides to derive any stabilization from interactions within the central C pocket to generate fully functional pMHC complexes. These results provide a structural explanation for a classical non-MHC-encoded H Ag, and they call into question the requirement for contact between anchor residues and the major MHC binding pockets in vaccine design.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 49 条
[1]  
Bristol JA, 1998, J IMMUNOL, V160, P2433
[2]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[3]   CAN ONE PREDICT ANTIGENIC PEPTIDES FOR MHC CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTES USEFUL FOR VACCINATION [J].
CALINLAURENS, V ;
TRESCOLBIEMONT, MC ;
GERLIER, D ;
RABOURDINCOMBE, C .
VACCINE, 1993, 11 (09) :974-978
[4]   Epitope selection and development of peptide based vaccines to treat cancer [J].
Celis, E ;
Sette, A ;
Grey, HM .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (06) :329-336
[5]   STRUCTURE OF AN ANTIBODY LYSOZYME COMPLEX UNEXPECTED EFFECT OF A CONSERVATIVE MUTATION [J].
CHACKO, S ;
SILVERTON, E ;
KAMMORGAN, L ;
SMITHGILL, S ;
COHEN, G ;
DAVIES, D .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 245 (03) :261-274
[6]  
Chesnut R W, 1995, Pharm Biotechnol, V6, P847
[7]   Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: The H60 histocompatibility antigen dominates over all others [J].
Choi, EY ;
Yoshimura, Y ;
Christianson, GJ ;
Sproule, TJ ;
Malarkannan, S ;
Shastri, N ;
Joyce, S ;
Roopenian, DC .
JOURNAL OF IMMUNOLOGY, 2001, 166 (07) :4370-4379
[8]  
Clay TM, 1999, J IMMUNOL, V162, P1749
[9]   A functional hot spot for antigen recognition in a superagonist TCR/MHC complex [J].
Degano, M ;
Garcia, KC ;
Apostolopoulos, V ;
Rudolph, MG ;
Teyton, L ;
Wilson, IA .
IMMUNITY, 2000, 12 (03) :251-261
[10]   Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical [J].
Ding, YH ;
Baker, BM ;
Garboczi, DN ;
Biddison, WE ;
Wiley, DC .
IMMUNITY, 1999, 11 (01) :45-56